Literature DB >> 9624298

Lung infections. 2. Branhamella catarrhalis: epidemiological and clinical aspects of a human respiratory tract pathogen.

T F Murphy1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9624298      PMCID： PMC1758713          DOI： 10.1136/thx.53.2.124

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  38 in total

1.  From Micrococcus to Moraxella. The reemergence of Branhamella catarrhalis.

Authors:  S L Berk
Journal:  Arch Intern Med       Date:  1990-11

2.  Evaluation of restriction endonuclease analysis as an epidemiologic typing system for Branhamella catarrhalis.

Authors:  J E Patterson; T F Patterson; P Farrel; W J Hierholzer; M J Zervos
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

3.  Branhamella catarrhalis pneumonia with bacteremia.

Authors:  P W Choo; N M Gantz
Journal:  South Med J       Date:  1989-10       Impact factor: 0.954

4.  Wound infection caused by Branhamella catarrhalis.

Authors:  L D Gray; R E Van Scoy; J P Anhalt; P K Yu
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

5.  Identification of Branhamella catarrhalis in 2.5 min with an indoxyl butyrate strip test.

Authors:  S F Dealler; M Abbott; M J Croughan; P M Hawkey
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

Review 6.  Branhamella catarrhalis: an organism gaining respect as a pathogen.

Authors:  B W Catlin
Journal:  Clin Microbiol Rev       Date:  1990-10       Impact factor: 26.132

7.  Comparison of the nasal bacterial floras in two groups of healthy subjects and in patients with acute maxillary sinusitis.

Authors:  H R Jousimies-Somer; S Savolainen; J S Ylikoski
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

8.  Esterase electrophoresis: a molecular tool for studying the epidemiology of Branhamella catarrhalis nosocomial infection.

Authors:  B Picard; P Goullet; E Denamur; G Suermondt
Journal:  Epidemiol Infect       Date:  1989-12       Impact factor: 2.451

9.  Branhamella catarrhalis septicemia in patients with leukemia.

Authors:  H Saito; E J Anaissie; N Khardori; G P Bodey
Journal:  Cancer       Date:  1988-06-01       Impact factor: 6.860

10.  Incidence of Branhamella catarrhalis in the sputa of patients with chronic lung disease.

Authors:  J A Pollard; R J Wallace; D R Nash; J I Luman; R W Wilson
Journal:  Drugs       Date:  1986       Impact factor: 9.546
View more
  14 in total

1.  Analysis of antigenic structure and human immune response to outer membrane protein CD of Moraxella catarrhalis.

Authors:  T F Murphy; C Kirkham; E DeNardin; S Sethi
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  The other siblings: respiratory infections caused by Moraxella catarrhalis and Haemophilus influenzae.

Authors:  Larry Lutwick; Laila Fernandes
Journal:  Curr Infect Dis Rep       Date:  2006-05       Impact factor: 3.725

3.  Pulmonary thin-section CT findings in acute Moraxella catarrhalis pulmonary infection.

Authors:  F Okada; Y Ando; T Nakayama; S Tanoue; R Ishii; A Ono; M Watanabe; H Takaki; T Maeda; H Mori
Journal:  Br J Radiol       Date:  2010-12-01       Impact factor: 3.039

Review 4.  Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review.

Authors:  S Sethi; T F Murphy
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

Review 5.  Moraxella catarrhalis: from emerging to established pathogen.

Authors:  Cees M Verduin; Cees Hol; André Fleer; Hans van Dijk; Alex van Belkum
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

6.  Moraxella catarrhalis outer membrane protein CD elicits antibodies that inhibit CD binding to human mucin and enhance pulmonary clearance of M. catarrhalis in a mouse model.

Authors:  Dai-Fang Liu; John C McMichael; Steven M Baker
Journal:  Infect Immun       Date:  2007-04-02       Impact factor: 3.441

7.  Expression of type IV pili by Moraxella catarrhalis is essential for natural competence and is affected by iron limitation.

Authors:  Nicole R Luke; Amy J Howlett; Jianqiang Shao; Anthony A Campagnari
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

8.  The rise and spread of a new pathogen: seroresistant Moraxella catarrhalis.

Authors:  Thierry Wirth; Giovanna Morelli; Barica Kusecek; Alex van Belkum; Cindy van der Schee; Axel Meyer; Mark Achtman
Journal:  Genome Res       Date:  2007-09-25       Impact factor: 9.043

9.  Identification of a 3-deoxy-D-manno-octulosonic acid biosynthetic operon in Moraxella catarrhalis and analysis of a KdsA-deficient isogenic mutant.

Authors:  Nicole R Luke; Simon Allen; Bradford W Gibson; Anthony A Campagnari
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

10.  Identification of a novel two-partner secretion locus in Moraxella catarrhalis.

Authors:  Pascale Plamondon; Nicole R Luke; Anthony A Campagnari
Journal:  Infect Immun       Date:  2007-04-09       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.